TITLE

What evidence could validate the definition of COPD?

AUTHOR(S)
de Marco, Roberto
PUB. DATE
September 2008
SOURCE
Thorax;Sep2008, Vol. 63 Issue 9, p756
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The article cites that the Global Initiative for Chronic Obstructive Lung Disease has defined chronic obstructive pulmonary disease (COPD) as a post-bronchodilator FEV1/FVC ratio <0.705. The definition was made in an attempt to simplify the diagnosis of COPD, improve the detection of the disease in primary care and standardize methods to measure its prevalence.
ACCESSION #
34395935

 

Related Articles

  • Diagnosis and treatment of patients with chronic obstructive pulmonary disease in the primary care setting: focus on the role of spirometry and bronchodilator reversibility. Stoloff, Stuart W. // Journal of Family Practice;Apr2011, Vol. 60 Issue 4, pS9 

    The article focuses on the treatment and diagnosis of patients with chronic obstructive pulmonary disease (COPD) in the primary care setting, the clinical relevance of acute bronchodilator reversity, and the role of spirometry in screening patients. It states that the use of spirometry is...

  • Diagnosis of chronic obstructive pulmonary disease in the primary care setting. Spyratos, D.; Chloros, D.; Sichletidis, L. // Hippokratia;Jan2012, Vol. 16 Issue 1, p17 

    Chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity and mortality with increasing rates during the last decades. Due to the progressive nature of the disease, underestimation of symptoms by the patients, lack of knowledge and underuse of spirometry by the Primary Care...

  • Short decision aid improves COPD diagnosis.  // Pulse;9/28/2011, Vol. 71 Issue 31, p9 

    The article reports on the importance of short decision in improving the diagnosis of chronic obstructive pulmonary disease (COPD).

  • Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes. van der Molen, Thys; Cazzola, Mario // Primary Care Respiratory Journal;Mar2012, Vol. 21 Issue 1, p101 

    Bronchodilators are central to the management of chronic obstructive pulmonary disease (COPD). Clinical studies combining different classes of bronchodilators, in particular a long-acting muscarinic antagonist (LAMA) and a long-acting β2-agonist (LABA), have demonstrated greater improvements...

  • Optimising pharmacological maintenance treatment for COPD in primary care. Jones, Rupert; Østrem, Anders // Primary Care Respiratory Journal;Mar2011, Vol. 20 Issue 1, p33 

    Chronic obstructive pulmonary disease (COPD) is a multi-faceted disease that is a major cause of morbidity and mortality worldwide, and is a significant burden in terms of healthcare resource utilisation and cost. Despite the availability of national and international guidelines, and effective,...

  • Medications for COPD: A Review of Effectiveness. Grimes, Gil C.; Manning, John L.; Patel, Parita; Via, R. Marc // American Family Physician;10/15/2007, Vol. 76 Issue 8, p1141 

    Chronic obstructive pulmonary disease (COPD) is a common problem among patients presenting to primary care. This condition has multiple individual and combined treatment regimens. The goals of treatment are to improve quality of life, exercise tolerance, sleep quality, and survival; and to...

  • Efficient screening for COPD using three steps: a cross-sectional study in Mexico City. Franco-Marina, Francisco; Fernandez-Plata, Rosario; Torre-Bouscoulet, Luis; García-Sancho, Cecilia; Sanchez-Gallen, Elisa; Martinez, David; Perez-Padilla, Rogelio // Primary Care Respiratory Society UK;5/20/2014, p1 

    BACKGROUND: Underdiagnosis of chronic obstructive pulmonary disease (COPD) in primary care can be improved by a more efficient screening strategy. AIMS: To evaluate a three-step method of screening for COPD consisting of an initial short questionnaire followed by measurement of forced expiratory...

  • INCREASING THE QUALITY OF COPD CASE FINDING, DIAGNOSIS AND MANAGEMENT THROUGH A PRIMARY CARE FINANCIAL INCENTIVE SCHEME IN INNER LONDON. Contreras, M. Calonge; Billett, J.; Restrick, L.; Sennett, K.; Cooper, C.; Stern, M. // Thorax;Dec2011 Supplement, pA159 

    Introduction and Objectives COPD is a major cause of mortality/morbidity in high smoking prevalence Primary Care Trusts (PCTs). Our PCT expected COPD prevalence (3.7%) is therefore high but recorded prevalence (2009/2010) was 1.4%, suggesting large numbers of undiagnosed patients. COPD, as the...

  • Editorial: Small Airways Disease and Asthma. Pesola, Gene R.; Ahmed, Ubair // Internet Journal of Asthma, Allergy & Immunology;2005, Vol. 4 Issue 1, p2 

    The article presents information on small airways disease (SAD) and asthma. The term small airway generally refers to about 7 to 19th generation airways with an inner diameter of about 2 to 0.5 mm. These airways are felt to be an important site of inflammation in both early chronic obstructive...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics